Stanley A. Plotkin is a scientific advisory board member and University of Pennsylvania emeritus professor. Until 1991, Plotkin was a pediatrics and microbiology professor there, a Wistar Institute virology professor, infectious diseases director, and senior physician.
Wataru Akahata co-founded VLP Therapeutics and is its director and chief executive officer. Akahata was a senior researcher at the Vaccine Research Center, National Institutes of Health, for over 10 years, developing vaccines against HIV and influenza.
The page lists Surface Antigen Display, i-αVLP, Interior Gene Delivery, Replicon, and Native Virus Modification, as well as cancer and malaria vaccines, cancer therapy, and native virus and dengue vaccines.
VLP Therapeutics' privacy policy, version 1.0, updated May 8, 2025, covers information collected, marketing, cookies and tracking, third parties, personal-information rights, and safeguarding.
